Cite
HARVARD Citation
Gopalakrishnan, M. et al. (2021). Shortened Positive and Negative Symptom Scale as an Alternate Clinical Endpoint for Acute Schizophrenia Trials: Analysis from the US Food & Drug Administration. Psychiatric Research and Clinical Practice. 3 (1), pp. 38-45. [Online].